129 related articles for article (PubMed ID: 36652779)
1. Retraction notice to "Bach2 regulates aberrant activation of B cell in systemic lupus erythematosus and can be negatively regulated by BCR-ABL/PI3K" [Exp. Cell Res. 365 (1), 1 April 2018, Pages 138-144].
Zhu Z; Yang C; Wen L; Liu L; Zuo X; Zhou F; Gao J; Zheng X; Shi Y; Zhu C; Liang B; Yin X; Wang W; Cheng H; Shen S; Tang X; Tang H; Sun L; Zhang A; Yang S; Cui Y; Zhang X; Sheng Y
Exp Cell Res; 2023 Feb; 423(2):113456. PubMed ID: 36652779
[No Abstract] [Full Text] [Related]
2. RETRACTED: Bach2 regulates aberrant activation of B cell in systemic lupus erythematosus and can be negatively regulated by BCR-ABL/PI3K.
Zhu Z; Yang C; Wen L; Liu L; Zuo X; Zhou F; Gao J; Zheng X; Shi Y; Zhu C; Liang B; Yin X; Wang W; Cheng H; Shen S; Tang X; Tang H; Sun L; Zhang A; Yang S; Cui Y; Zhang X; Sheng Y
Exp Cell Res; 2018 Apr; 365(1):138-144. PubMed ID: 29501569
[TBL] [Abstract][Full Text] [Related]
3. BACH2 regulates the function of human CD4
Zheng Y; Lu Y; Huang X; Han L; Chen Z; Zhou B; Ma Y; Xie G; Yang J; Bian B; Li L; Nie H; Pan X; Shen L
Eur J Immunol; 2020 Mar; 50(3):426-438. PubMed ID: 31808546
[TBL] [Abstract][Full Text] [Related]
4. Transcription factor BACH2 is transcriptionally regulated by the BCR/ABL oncogene.
Vieira SA; Deininger MW; Sorour A; Sinclair P; Foroni L; Goldman JM; Melo JV
Genes Chromosomes Cancer; 2001 Dec; 32(4):353-63. PubMed ID: 11746976
[TBL] [Abstract][Full Text] [Related]
5. Transcriptional suppression of BACH2 by the Bcr-Abl oncoprotein is mediated by PAX5.
Casolari DA; Makri M; Yoshida C; Muto A; Igarashi K; Melo JV
Leukemia; 2013 Feb; 27(2):409-15. PubMed ID: 22858985
[TBL] [Abstract][Full Text] [Related]
6. Bach2 overexpression represses Th9 cell differentiation by suppressing IRF4 expression in systemic lupus erythematosus.
Sheng Y; Zhang J; Li K; Wang H; Wang W; Wen L; Gao J; Tang X; Tang H; Huang H; Cai M; Yuan T; Liu L; Zheng X; Zhu Z; Cui Y
FEBS Open Bio; 2021 Feb; 11(2):395-403. PubMed ID: 33249782
[TBL] [Abstract][Full Text] [Related]
7. Nuclear positioning of the BACH2 gene in BCR-ABL positive leukemic cells.
Ono A; Kono K; Ikebe D; Muto A; Sun J; Kobayashi M; Ueda K; Melo JV; Igarashi K; Tashiro S
Genes Chromosomes Cancer; 2007 Jan; 46(1):67-74. PubMed ID: 17044046
[TBL] [Abstract][Full Text] [Related]
8. Bach2 deficiency leads autoreactive B cells to produce IgG autoantibodies and induce lupus through a T cell-dependent extrafollicular pathway.
Jang E; Kim UK; Jang K; Song YS; Cha JY; Yi H; Youn J
Exp Mol Med; 2019 Dec; 51(12):1-13. PubMed ID: 31819031
[TBL] [Abstract][Full Text] [Related]
9. BCR/ABL regulates expression of the cyclin-dependent kinase inhibitor p27Kip1 through the phosphatidylinositol 3-Kinase/AKT pathway.
Gesbert F; Sellers WR; Signoretti S; Loda M; Griffin JD
J Biol Chem; 2000 Dec; 275(50):39223-30. PubMed ID: 11010972
[TBL] [Abstract][Full Text] [Related]
10. PI3K isoform inhibition associated with anti Bcr-Abl drugs shows in vitro increased anti-leukemic activity in Philadelphia chromosome-positive B-acute lymphoblastic leukemia cell lines.
Ultimo S; Simioni C; Martelli AM; Zauli G; Evangelisti C; Celeghini C; McCubrey JA; Marisi G; Ulivi P; Capitani S; Neri LM
Oncotarget; 2017 Apr; 8(14):23213-23227. PubMed ID: 28390196
[TBL] [Abstract][Full Text] [Related]
11. Bach2 in CD4
Long D; Yang B; Yang M; Xiong F; Zhu X; Tan Y; Wu H
Eur J Immunol; 2023 Apr; 53(4):e2250109. PubMed ID: 36781170
[TBL] [Abstract][Full Text] [Related]
12. Aberrant HS1 molecule in a patient with systemic lupus erythematosus.
Sawabe T; Horiuchi T; Koga R; Tsukamoto H; Kojima T; Harashima S; Kikuchi Y; Otsuka J; Mitoma H; Yoshizawa S; Niho Y; Watanabe T
Genes Immun; 2003 Mar; 4(2):122-31. PubMed ID: 12618860
[TBL] [Abstract][Full Text] [Related]
13. Bcr-Abl signaling through the PI-3/S6 kinase pathway inhibits nuclear translocation of the transcription factor Bach2, which represses the antiapoptotic factor heme oxygenase-1.
Yoshida C; Yoshida F; Sears DE; Hart SM; Ikebe D; Muto A; Basu S; Igarashi K; Melo JV
Blood; 2007 Feb; 109(3):1211-9. PubMed ID: 17018862
[TBL] [Abstract][Full Text] [Related]
14. Ablation of PI3K blocks BCR-ABL leukemogenesis in mice, and a dual PI3K/mTOR inhibitor prevents expansion of human BCR-ABL+ leukemia cells.
Kharas MG; Janes MR; Scarfone VM; Lilly MB; Knight ZA; Shokat KM; Fruman DA
J Clin Invest; 2008 Sep; 118(9):3038-50. PubMed ID: 18704194
[TBL] [Abstract][Full Text] [Related]
15. Aberrant B-Cell Activation in Systemic Lupus Erythematosus.
Kang N; Liu X; You X; Sun W; Haneef K; Sun X; Liu W
Kidney Dis (Basel); 2022 Dec; 8(6):437-445. PubMed ID: 36590680
[TBL] [Abstract][Full Text] [Related]
16. Differential effects of selective inhibitors targeting the PI3K/AKT/mTOR pathway in acute lymphoblastic leukemia.
Badura S; Tesanovic T; Pfeifer H; Wystub S; Nijmeijer BA; Liebermann M; Falkenburg JH; Ruthardt M; Ottmann OG
PLoS One; 2013; 8(11):e80070. PubMed ID: 24244612
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of the PI3K/Akt/GSK3 pathway downstream of BCR/ABL, Jak2-V617F, or FLT3-ITD downregulates DNA damage-induced Chk1 activation as well as G2/M arrest and prominently enhances induction of apoptosis.
Kurosu T; Nagao T; Wu N; Oshikawa G; Miura O
PLoS One; 2013; 8(11):e79478. PubMed ID: 24260231
[TBL] [Abstract][Full Text] [Related]
18. Bcr-Abl-mediated redox regulation of the PI3K/AKT pathway.
Naughton R; Quiney C; Turner SD; Cotter TG
Leukemia; 2009 Aug; 23(8):1432-40. PubMed ID: 19295548
[TBL] [Abstract][Full Text] [Related]
19. An early-onset SLE patient with a novel paternal inherited BACH2 mutation.
Zhou L; Sun G; Chen R; Chen J; Fang S; Xu Q; Tang W; Dai R; Zhang Z; An Y; Tang X; Zhao X
J Clin Immunol; 2023 Aug; 43(6):1367-1378. PubMed ID: 37148421
[TBL] [Abstract][Full Text] [Related]
20. Bach2 Promotes B Cell Receptor-Induced Proliferation of B Lymphocytes and Represses Cyclin-Dependent Kinase Inhibitors.
Miura Y; Morooka M; Sax N; Roychoudhuri R; Itoh-Nakadai A; Brydun A; Funayama R; Nakayama K; Satomi S; Matsumoto M; Igarashi K; Muto A
J Immunol; 2018 Apr; 200(8):2882-2893. PubMed ID: 29540581
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
